Literature DB >> 18038126

Noradrenergic-glucocorticoid mechanisms in emotion-induced amnesia: from adaptation to disease.

René Hurlemann1.   

Abstract

DISCUSSIONS: The interaction of emotion and episodic encoding has costs and benefits. These costs and benefits have been characterized in oddball experiments, where a violation of prevailing neutral context through aversive oddballs is associated with subsequent hypermnesia for the aversive oddball and peri-emotional amnesia for the neutral context. Both hypermnesia and peri-emotional amnesia are amygdala-dependent and vary as a function of noradrenergic-glucocorticoid input to the amygdala during emotional episodic encoding. Pharmacological enhancement of this input allows to model the maladaptive effects of emotion on episodic encoding. Extrapolation of these findings to conditions of emotional trauma suggests that disinhibited noradrenergic-glucocorticoid signaling could serve as a crucial etiological contributor to the pathogenesis of peri-traumatic amnesia (PTA) and post-traumatic stress disorder (PTSD).
CONCLUSIONS: Immediate pharmacological blockade of noradrenergic-glucocorticoid signaling might prove effective in the secondary prevention of PTA and PTSD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038126     DOI: 10.1007/s00213-007-1002-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  121 in total

Review 1.  Memory--a century of consolidation.

Authors:  J L McGaugh
Journal:  Science       Date:  2000-01-14       Impact factor: 47.728

2.  Cognitive and neural mechanisms of emotional memory.

Authors:  S Hamann
Journal:  Trends Cogn Sci       Date:  2001-09-01       Impact factor: 20.229

3.  Confidence, not consistency, characterizes flashbulb memories.

Authors:  Jennifer M Talarico; David C Rubin
Journal:  Psychol Sci       Date:  2003-09

4.  The effect of emotion on cue utilization and the organization of behavior.

Authors:  J A EASTERBROOK
Journal:  Psychol Rev       Date:  1959-05       Impact factor: 8.934

Review 5.  Efficacy of hydrocortisone in preventing posttraumatic stress disorder following critical illness and major surgery.

Authors:  Gustav Schelling; Benno Roozendaal; Till Krauseneck; Martin Schmoelz; Dominique DE Quervain; Josef Briegel
Journal:  Ann N Y Acad Sci       Date:  2006-07       Impact factor: 5.691

6.  Glucocorticoids reduce phobic fear in humans.

Authors:  Leila M Soravia; Markus Heinrichs; Amanda Aerni; Caroline Maroni; Gustav Schelling; Ulrike Ehlert; Benno Roozendaal; Dominique J-F de Quervain
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

7.  Encoding processes and memory organization: a model of the von Restorff effect.

Authors:  M Fabiani; E Donchin
Journal:  J Exp Psychol Learn Mem Cogn       Date:  1995-01       Impact factor: 3.051

8.  Peritraumatic and persistent dissociation in the presumed etiology of PTSD.

Authors:  John Briere; Catherine Scott; Frank Weathers
Journal:  Am J Psychiatry       Date:  2005-12       Impact factor: 18.112

9.  Low-dose cortisol for symptoms of posttraumatic stress disorder.

Authors:  Amanda Aerni; Rafael Traber; Christoph Hock; Benno Roozendaal; Gustav Schelling; Andreas Papassotiropoulos; Roger M Nitsch; Ulrich Schnyder; Dominique J-F de Quervain
Journal:  Am J Psychiatry       Date:  2004-08       Impact factor: 18.112

Review 10.  Nongenomic actions of steroid hormones.

Authors:  Ralf Lösel; Martin Wehling
Journal:  Nat Rev Mol Cell Biol       Date:  2003-01       Impact factor: 94.444

View more
  10 in total

Review 1.  Emotional oddball: A review on memory effects.

Authors:  Helge Schlüter; Ryan P Hackländer; Christina Bermeitinger
Journal:  Psychon Bull Rev       Date:  2019-10

Review 2.  Pharmacological treatment of PTSD - established and new approaches.

Authors:  Thomas Steckler; Victoria Risbrough
Journal:  Neuropharmacology       Date:  2011-06-29       Impact factor: 5.250

3.  Stress-induced cardiomyopathy and possible link to cerebral executive function: a case report.

Authors:  Samuel L Sidharta; Jithin K Sajeev; Adam J Nelson; Jennifer C Cooke; Matthew I Worthley
Journal:  Prim Care Companion CNS Disord       Date:  2013

4.  Stress and glucocorticoids impair memory retrieval via β2-adrenergic, Gi/o-coupled suppression of cAMP signaling.

Authors:  Keith Schutsky; Ming Ouyang; Christina B Castelino; Lei Zhang; Steven A Thomas
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

5.  GANEing traction: The broad applicability of NE hotspots to diverse cognitive and arousal phenomena.

Authors:  Mara Mather; David Clewett; Michiko Sakaki; Carolyn W Harley
Journal:  Behav Brain Sci       Date:  2016-01       Impact factor: 12.579

Review 6.  The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.

Authors:  Elizabeth I Martin; Kerry J Ressler; Elisabeth Binder; Charles B Nemeroff
Journal:  Psychiatr Clin North Am       Date:  2009-09

7.  Noradrenergic enhancement of amygdala responses to fear.

Authors:  Oezguer A Onur; Henrik Walter; Thomas E Schlaepfer; Anne K Rehme; Christoph Schmidt; Christian Keysers; Wolfgang Maier; René Hurlemann
Journal:  Soc Cogn Affect Neurosci       Date:  2009-02-25       Impact factor: 3.436

Review 8.  Pharmacotherapy of PTSD: premises, principles, and priorities.

Authors:  Lakshmi N Ravindran; Murray B Stein
Journal:  Brain Res       Date:  2009-03-28       Impact factor: 3.252

9.  Inferior frontal gyrus preserves working memory and emotional learning under conditions of impaired noradrenergic signaling.

Authors:  Benjamin Becker; Lucas Androsch; Ralph T Jahn; Therese Alich; Nadine Striepens; Sebastian Markett; Wolfgang Maier; René Hurlemann
Journal:  Front Behav Neurosci       Date:  2013-12-17       Impact factor: 3.558

10.  Noradrenergic projections from the locus coeruleus to the amygdala constrain fear memory reconsolidation.

Authors:  Josué Haubrich; Matteo Bernabo; Karim Nader
Journal:  Elife       Date:  2020-05-18       Impact factor: 8.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.